knowledge -WSS

knowledge

author：knowledge 2025-10-02 20:47:13 - browse：396

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

focus

WSS

Duchenne breakthrough therapy leaves behind pioneering families

Psychedelics group wrestles with new pharma identity

Sports medicine is finally prioritizing gender equality

In age of alternative facts, a scholarly course on calling out crap

Dobbs anniversary: the lost opportunity of abortion as health care

WuXi Biologics execs register to lobby as Congress comes for the company

Wikipedia

knowledge

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

ALS treatment from Biogen, Ionis fails in study

Medicare proposal to cover medical devices draws a mixed reaction

Lilly’s weekly insulin works as well as daily products, new studies show

Heart attack and stroke risk calculators need revising

HHS suspends federal funding for EcoHealth Alliance

New air purifier tech could be key to improving indoor air quality

Heart attack and stroke risk calculators need revising

Trump demands the U.S. pay no more for drugs than other countries … again

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Anesthesiologist group: stop taking Ozempic before surgery

The White House hikes tariffs on plastic syringes made in China

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Hottest summer in 2,000 years puts focus on extreme heat, health

In age of alternative facts, a scholarly course on calling out crap

focus

focus

leisure time

focus